#Syenex
LightNews LightNews
paultcarman.bsky.social
Exciting collaboration news from our CellFE team in the pursuit of advancing cell therapy production!

www.prnewswire.com/news-release...
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
/PRNewswire/ -- CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative...
www.prnewswire.com
January 9, 2025 at 3:53 PM
josh-leonard.bsky.social
We believe this technology can be extended to solve all manner of delivery challenges for gene and cell therapy. Check out the story behind the paper and our recent spin-out which is bringing GEMINI to the world through Syenex
 
news.northwestern.edu/stories/2023...
New platform solves key problems in targeted drug delivery
Research potentially removes barriers for promising cell and gene therapies
news.northwestern.edu
November 27, 2023 at 5:23 PM
longtail-news.bsky.social
Feed: "GEN – Genetic Engineering and Biotechnology News"
By: John Sterling on Friday, January 9, 2026
Bionova Scientific and Syenex Enter Plasmid DNA Alliance
Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.
www.genengnews.com
January 10, 2026 at 11:49 AM
newsen.bsky.social
Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries#United_States#Houston#Syenex#Bionova_Scientific#Plasmid_DNA
Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries
Bionova Scientific and Syenex have teamed up to enhance global access to high-quality plasmid DNA, pivotal for advanced gene therapies.
third-news.com
January 8, 2026 at 4:51 PM
newsen.bsky.social
Leucid Bio and Syenex Forge Partnership for Innovative CAR-T Cell Engineering#London#CAR-T_therapy#Syenex#Leucid_Bio
Leucid Bio and Syenex Forge Partnership for Innovative CAR-T Cell Engineering
Leucid Bio and Syenex have entered a partnership to develop an innovative in vivo CAR-T cell therapy, aiming to improve cancer treatment using LEU011 and Syenex's VivoCell Platform.
third-news.com
December 15, 2025 at 1:55 PM
newsen.bsky.social
Transforming T Cell Therapy Manufacturing: A Revolutionary Partnership between Made Scientific and Syenex#USA#Princeton#Syenex#T_Cell_Therapy#Made_Scientific
Transforming T Cell Therapy Manufacturing: A Revolutionary Partnership between Made Scientific and Syenex
Made Scientific and Syenex have partnered to enhance T cell therapy manufacturing efficiency and scalability through innovative technology, addressing industry challenges.
third-news.com
September 30, 2025 at 5:55 PM
newsen.bsky.social
ARTAN Bio and Syenex Collaborate on Revolutionary Aging Treatments Using VivoCell Technology#USA#Syenex#ARTAN_Bio#VivoCell#Houston,Chicago
ARTAN Bio and Syenex Collaborate on Revolutionary Aging Treatments Using VivoCell Technology
ARTAN Bio teams up with Syenex to enhance drug delivery for aging treatments. This collaboration aims to accelerate innovative solutions for age-related health issues.
third-news.com
June 30, 2025 at 11:55 AM
newsen.bsky.social
Innovative Collaboration Between CellFE and Syenex to Enhance Cell Engineering Methods#USA#San_Francisco#Gene_Editing#CellFE#Syenex
Innovative Collaboration Between CellFE and Syenex to Enhance Cell Engineering Methods
CellFE and Syenex are collaborating to develop an advanced hybrid workflow that integrates non-viral and viral gene editing for more efficient cell therapy manufacturing.
third-news.com
January 9, 2025 at 3:12 PM
l2plabs.bsky.social
Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM LONDON and CHICAGO, Dec. 15, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using its...
dlvr.it
December 15, 2025 at 1:33 PM
l2plabs.bsky.social
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ -- CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates…
dlvr.it
January 9, 2025 at 3:34 PM
byteseu.bsky.social
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing

https://www.byteseu.com/1409737/

PRINCETON, N.J. and CHICAGO, Sept. 30, 2025 /PRNewswire/ — Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and …
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing - Bytes Europe
Syenex and Made will continue to build upon initial proof of concept with Syenex's bioengineering platforms to address scalability and cost challenges of
www.byteseu.com
October 1, 2025 at 8:13 AM
drtimos.bsky.social
Signal or noise? > Made Scientific and Syenex Forge Technology Partnership to
Transform T Cell Therapy Manufacturing - PR Newswire >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #competitivemarketing #pharma #pharmaceutical
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing - PR Newswire
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing  PR Newswire
dlvr.it
September 30, 2025 at 4:29 PM
drtimos.bsky.social
Thoughts on this? >> CTMC and Syenex Launch Partnership to Accelerate Scalability
of Cell Therapies - Business Wire: CTMC and Syenex Launch Partnership to Accelerate… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #pharmaceutical #healthcare
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies - Business Wire
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies  Business Wire
dlvr.it
January 8, 2025 at 2:00 PM